Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
NVRO | US
-0.19
-3.68%
Healthcare
Medical Devices
30/06/2024
04/10/2024
4.97
5.10
5.13
4.81
Nevro Corp. a medical device company provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation (SCS) system an evidence-based neuromodulation system for the treatment of chronic pain as well as Senza II and Senza Omnia SCS systems. It also provides 10 kHz Therapy which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company's Senza HFX iQ IPG system includes HFX iQ implantable pulse generator HFX trial stimulator and HFX iQ patient remote as well as HFX App a patient remote control and the wireless trialing system. In addition it offers surpass surgical and percutaneous leads. The company sells its products through its direct sales force and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City California.
View LessValue Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
High Debt to Equity (> 0.75)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
58.4%1 month
75.1%3 months
125.1%6 months
98.1%-
-
0.72
0.88
0.40
-4.79
0.39
-3.13
-84.49M
185.30M
185.30M
-
-23.20
-
-4.30
-27.22
4.73
9.05
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
1.05
Range1M
1.61
Range3M
5.99
Rel. volume
0.53
Price X volume
1.35M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Neuropace Inc. Common Stock | NPCE | Medical Devices | 6.83 | 199.42M | -1.44% | n/a | 745.17% |
Accuray Incorporated | ARAY | Medical Devices | 1.91 | 191.51M | 7.91% | n/a | 467.45% |
CVRx Inc. | CVRX | Medical Devices | 8.78 | 191.28M | 1.04% | n/a | 55.37% |
Electromed Inc | ELMD | Medical Devices | 21.66 | 187.12M | -1.32% | 35.00 | 0.20% |
Semler Scientific Inc | SMLR | Medical Devices | 24.99 | 174.74M | 3.48% | 11.71 | 0.15% |
Stereotaxis Inc | STXS | Medical Instruments & Supplies | 2.04 | 172.70M | 4.62% | n/a | 31.50% |
BRAINSWAY LTD | BWAY | Medical Devices | 9.5 | 158.44M | 5.56% | 403.50 | 10.16% |
InfuSystem Holdings Inc | INFU | Medical Instruments & Supplies | 6.75 | 143.88M | 2.58% | 675.00 | 73.21% |
Lakeland Industries Inc | LAKE | Medical Instruments & Supplies | 19.25 | 142.38M | -1.43% | 77.62 | 35.09% |
TriSalus Life Sciences Inc. | TLSI | Medical Devices | 4.55 | 133.37M | 2.25% | 0.09 | -94.26% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
STHO | STHO | Real Estate Services | 13 | 173.15M | -3.20% | n/a | 59.21% |
Douglas Elliman Inc. | DOUG | Real Estate Services | 1.66 | 152.44M | -7.26% | n/a | 62.82% |
Comstock Holding Companies Inc | CHCI | Real Estate Services | 11.7 | 115.38M | 14.71% | 11.75 | 17.12% |
Comstock Mining Inc | LODE | Real Estate Services | 0.521 | 107.66M | 21.16% | 6.09 | 14.37% |
OPAD | OPAD | Real Estate Services | 3.39 | 92.73M | -5.31% | n/a | 406.11% |
Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 31.64 | 90.86M | -0.32% | 5.47 | 19.82% |
Saga Communications Inc | SGA | Broadcasting - Radio | 14 | 87.66M | -1.27% | 14.62 | 7.10% |
Urban One Inc | UONEK | Broadcasting - Radio | 1.02 | 57.65M | -4.67% | n/a | 268.43% |
Fathom Holdings Inc | FTHM | Real Estate Services | 2.7 | 56.72M | 3.45% | n/a | 36.20% |
The InterGroup Corporation | INTG | Real Estate Services | 16.4 | 35.87M | 7.75% | n/a | -257.98% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -4.79 | 45.99 | Cheaper |
Ent. to Revenue | 0.39 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 0.72 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 125.11 | 66.08 | Riskier |
Debt to Equity | 0.88 | 0.83 | Par |
Debt to Assets | 0.40 | 0.28 | Expensive |
Market Cap | 185.30M | 9.42B | Emerging |